Veterinary vaccine adjuvant, method of making and use thereof
A veterinary vaccine adjuvant was prepared by combining lactic acid-glycolic acid copolymer, saponins, and pine pollen, which solved the problems of high viscosity and serious side effects of existing adjuvants, and achieved a highly efficient, safe immune response and long-term protection.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- JINYUBAOLING BIO PHARMA CO LTD
- Filing Date
- 2026-04-17
- Publication Date
- 2026-07-14
AI Technical Summary
Existing veterinary vaccine adjuvants suffer from problems such as high viscosity, severe side effects, and short duration of immune protection, making it difficult to meet the requirements of good stability, high safety, and strong immunogenicity.
A combination of lactic acid-glycolic acid copolymer, saponins, mannose and pine pollen was used to prepare veterinary vaccine adjuvants through a specific process. The PLGA nanoparticle delivery system was used to enhance the immune response and reduce drug loss.
The prepared vaccine adjuvant significantly enhances the speed and intensity of specific immune responses, activates non-specific defense mechanisms, improves disease resistance, and has high safety, long duration of immune response, strong stability, and is suitable for the application of multiple antigens.
Smart Images

Figure CN122376727A_ABST